171 related articles for article (PubMed ID: 36153352)
1. FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms.
Hurley MM; Coffin JD; Doetschman T; Valera C; Clarke K; Xiao L
Sci Rep; 2022 Sep; 12(1):15968. PubMed ID: 36153352
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L; Du E; Homer-Bouthiette C; Hurley MM
Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms.
Xiao L; Williams D; Hurley MM
Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31901095
[TBL] [Abstract][Full Text] [Related]
4. FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.
Meo Burt P; Xiao L; Hurley MM
Endocrinology; 2018 Jun; 159(6):2386-2396. PubMed ID: 29718273
[TBL] [Abstract][Full Text] [Related]
5. FGF2 High Molecular Weight Isoforms Contribute to Osteoarthropathy in Male Mice.
Meo Burt P; Xiao L; Dealy C; Fisher MC; Hurley MM
Endocrinology; 2016 Dec; 157(12):4602-4614. PubMed ID: 27732085
[TBL] [Abstract][Full Text] [Related]
6. FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice.
Xiao L; Homer-Bouthiette C; Hurley MM
J Bone Miner Res; 2018 Jul; 33(7):1347-1361. PubMed ID: 29502359
[TBL] [Abstract][Full Text] [Related]
7. FGFR Inhibitor Ameliorates Hypophosphatemia and Impaired Engrailed-1/Wnt Signaling in FGF2 High Molecular Weight Isoform Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Biochem; 2016 Sep; 117(9):1991-2000. PubMed ID: 26762209
[TBL] [Abstract][Full Text] [Related]
8. Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection.
Burt PM; Xiao L; Doetschman T; Hurley MM
J Cell Physiol; 2019 Apr; 234(4):4418-4431. PubMed ID: 30144364
[TBL] [Abstract][Full Text] [Related]
9. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.
Xiao L; Esliger A; Hurley MM
J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867
[TBL] [Abstract][Full Text] [Related]
10. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice.
Shen J; Li J; Wang B; Jin H; Wang M; Zhang Y; Yang Y; Im HJ; O'Keefe R; Chen D
Arthritis Rheum; 2013 Dec; 65(12):3107-19. PubMed ID: 23982761
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Growth Factor Receptor 3 Inhibits Osteoarthritis Progression in the Knee Joints of Adult Mice.
Tang J; Su N; Zhou S; Xie Y; Huang J; Wen X; Wang Z; Wang Q; Xu W; Du X; Chen H; Chen L
Arthritis Rheumatol; 2016 Oct; 68(10):2432-43. PubMed ID: 27159076
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
[TBL] [Abstract][Full Text] [Related]
14. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
[TBL] [Abstract][Full Text] [Related]
15. miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage.
Ji Q; Xu X; Xu Y; Fan Z; Kang L; Li L; Liang Y; Guo J; Hong T; Li Z; Zhang Q; Ye Q; Wang Y
J Mol Med (Berl); 2016 Jun; 94(6):681-94. PubMed ID: 26816250
[TBL] [Abstract][Full Text] [Related]
16. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.
Yan D; Chen D; Cool SM; van Wijnen AJ; Mikecz K; Murphy G; Im HJ
Arthritis Res Ther; 2011 Aug; 13(4):R130. PubMed ID: 21835001
[TBL] [Abstract][Full Text] [Related]
19. Velvet antler polypeptide partially rescue facet joint osteoarthritis-like phenotype in adult β-catenin conditional activation mice.
Xie WQ; Zhao YJ; Li F; Shu B; Lin SR; Sun L; Wang YJ; Zheng HX
BMC Complement Altern Med; 2019 Jul; 19(1):191. PubMed ID: 31362725
[TBL] [Abstract][Full Text] [Related]
20. Isoimperatorin ameliorates osteoarthritis by downregulating the mammalian target of rapamycin C1 signaling pathway.
Ouyang J; Jiang H; Fang H; Cui W; Cai D
Mol Med Rep; 2017 Dec; 16(6):9636-9644. PubMed ID: 29039501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
